HUTCHMED (China) Limited American Depositary Shares (HCM)

FairStock Score: 57/100 — STEADY

Key Financials

Strengths

• High return on equity of 45.3% demonstrating efficient capital deployment
• Conservative balance sheet with debt-to-equity of just 0.08, providing financial flexibility

Concerns

• Currently unprofitable—sustained losses could lead to dilutive capital raises or balance sheet deterioration
• Weak Piotroski F-Score of 1/9 suggests deteriorating financial quality across multiple dimensions

AI Analysis

HUTCHMED (China) Limited American Depositary Shares is a small-cap healthcare company valued at $2.4 billion. Revenue stands at $549 million, though the company is currently unprofitable. From a quality standpoint, HUTCHMED shows weak Piotroski F-Score of 1/9 signaling deteriorating fundamentals and healthy Altman Z-Score of 3.4. On valuation, the stock is deeply undervalued on a P/E basis at 5.2x, with trades above its Graham Number with a negative 49% margin. Our composite FairStock Score of 57/100 reflects mixed fundamentals overall. This combination of reasonable valuation, solid returns, and conservative leverage makes it worth a closer look for value-oriented portfolios.

Bull Case

The market underappreciates HUTCHMED's consistent 45% ROE at just 5x earnings—a re-rating toward sector peers could unlock 30-50% upside. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.

Bear Case

Without a clear path to profitability, continued cash burn forces either dilutive equity raises or debt accumulation that destroys shareholder value. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer